The Potential of Genetically Altered Mice as Animal Models for Carcinogen Identification

1. Asano S , Trempus CS , Spalding JW , Tennant RW , and Battalora MS (1998). Morphological characterization of spindle cell tumors induced in transgenic Tg.AC mouse skin. Toxicol. Pathol. 26: 512–519 (this issue).

2. Ashby J (1997). Identifying potential human carcinogens–The role of genetically altered rodents. Toxicol Pathol. 25: 241–243.

3. Blanchard KT , Ball DJ , Holden HE , Furst SM , Stoltz JH , and Stoll RE (1998). Dermal carcinogenicity in transgenic mice: Relative responsiveness of male and female hemizygous and homozygous Tg.AC mice to 12-O-tetradecanoylphorbol 13-acetate (TPA) and benzene. Toxicol. Pathol. 26: 541–547 (this issue).

4. Donehower LA , Harvey M , Slagle BL , McArthur MJ , Montgomery CA , Butel JS , and Bradley A (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356: 215–221.

5. Eastin WC , Hascman JK , Mahler JF , and Bucher JR (1998). The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying carcinogens. Toxicol. Pathol. 26: 461–473 (this issue).

6. Enomoto A , Sandgren EP , and Maronpot RR (1998). Altered differentiation of hepatocytes in a transgenic mouse model of hepatocarcin-ogenesis. Toxicol. Pathol. 26: 570–578 (this issue).

7. Finch GL , March TH , Hahn FF , Barr EB , Belinsky SA , Hoover MD , Lechner JF , Nikula KJ , and Hobbs CH (1998). Carcinogenic responses of transgenic heterozygous p53 knockout mice to inhaled 239PuO2 or metallic beryllium. Toxicol. Pathol. 26: 484–491 (this issue).

8. Harvey M , McArthur M , Montgomery C Jr , Butel J , Bradley A , and Donehower L (1993). Spontaneous and carcinogen-induced tu-morigenesis in p55-deficient mice. Nat. Genet.. 5: 225–229.

9. Hayashi S , Mori I , Nonoyama T , and Mitsumori K (1998). Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene. Toxicol. Pathol. 26: 556–561 (this issue).

10. Humble MC , Szczesniak CJ , Luetteke NC , Spalding JW , Cannon RE , Hansen LA , Lee DC , and Tennant RW (1998). TGFα is dispensable for skin tumorigcnesis in Tg.AC mice. Toxicol. Pathol. 26: 562–569 (this issue).

11. Mahler JF , Flagler ND , Malarkey DE , Mann PC , Haseman JK , and Eastin W (1998). Spontaneous and chemically induced proliferative lesions in Tg.AC transgenic and p53-heterozygous mice. Toxicol. Pathol. 26: 501–511 (this issue).

12. Mitsumori K , Koizumi H , Nomura T , and Yamamoto S (1998). Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol. Pathol. 26: 520–531 (this issue).

13. Nylander-French LA and French JE (1998). Tripropylene glycol diacrylate but not ethyl acrylate induces skin tumors in a twenty-week short-term tumorigenesis study in Tg.AC (v-Ha-ras) mice. Toxicol. Pathol. 26: 476–483 (this issue).

14. Robinson D (1998). The International Life Sciences Institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk. Toxicol. Pathol. 26: 474–475 (this issue).

15. Sagartz JE , Curtiss SW , Bunch RT , Davila JC , Morris DL , and Alden CL (1998). Phenobarbital does not promote hepatic tumorigenesis in a twenty-six-week bioassay in p53 heterozygous mice. Toxicol. Pathol. 26: 492–500 (this issue).

16. Saitoh A , Kimura M , Takahashi R , Yokoyama M , Nomura T , Izawa M , Sekiya T , Nishimura S , and Katsuki M (1990). Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene. 5: 1195–1200.

17. Smith PF (1996). Third international conference on harmonization of technical requirements for registration of pharmaceuticals for human use–A toxicologist's perspective. Toxicol. Pathol. 24:519–528.

18. Tennant RW , French JE , and Spalding JW (1995). Identifying chemical carcinogens and assessing potential risk in short-term bio-assays using transgenic mouse models. Environ. Health Perspect.. 103: 942–950.

19. Tennant RW , Stasiewicz S , Mennear J , French JE , and Spalding JW (in press). Genetically altered mouse models for carcinogen identification. IARC Monogr. Eval. Carcinog. Risks Hum.

20. Thompson KL , Rosenzweig BA , and Sistare FD (1998). An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness. Toxicol. Pathol. 26: 548–555 (this issue).

21. Weaver JL , Contrera JF . Rosenzweig BA . Thompson KL , Faustino PJ . Strong JM , Ellison CD , Anderson LW , Prasanna HR , Long-Bradley PE , Lin KK , Zhang J , and Sistare FD (1998). An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder pheno-type. Toxicol. Pathol. 26: 532–540 (this issue).